Week43, 2023
1. Seasonal influenza activity remains low nationally, with 1.9% of respiratory specimens testing positive, showing slight increases in some regions.
   
2. Public health labs reported 189 positive specimens; 76.7% were Influenza A (85.7% subtype A(H1N1), 14.3% A(H3N2)), and 23.3% were Influenza B (all Victoria lineage).

3. Outpatient visits for influenza-like illness (ILI) increased slightly to 2.7% but remain below the baseline of 2.9%; ILI activity is highest in Region 4 (Southeast).

4. A cumulative hospitalization rate of 0.8 per 100,000 was reported, with 1,607 flu-related hospitalizations, reflecting an increasing weekly trend.

5. Influenza-attributed deaths accounted for 0.06%, stable compared to previous weeks, with one new pediatric death for the 2023-24 season.

6. Influenza A made up 70.1% of clinical lab reports and Influenza B 29.9%; of the A subtypes, 85.7% were A(H1N1), with no novel influenza variants detected.

7. Integrated surveillance, including influenza, COVID-19, and RSV, highlights the co-circulation of respiratory viruses influencing ILI trends.

8. CDC recommends annual influenza vaccination for everyone 6 months and older; no updates on vaccination rates were provided this week.

9. Respiratory illness activity was moderate in 6 jurisdictions and high in 2, with increasing trends across most age groups and regions.

10. Flu activity is anticipated to rise, supported by increasing positive tests, ILI visits, and hospitalizations. Early antiviral treatment is encouraged.